Teladoc Health, Inc. (TDOC)
NYSE: TDOC · IEX Real-Time Price · USD
12.98
-0.20 (-1.52%)
At close: Apr 19, 2024, 4:00 PM
12.92
-0.06 (-0.46%)
After-hours: Apr 19, 2024, 7:19 PM EDT

Teladoc Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013
Revenue
2,6022,4072,0331,094553.31417.91233.28123.1677.3843.53
Upgrade
Revenue Growth (YoY)
8.13%18.41%85.81%97.71%32.40%79.14%89.42%59.15%77.78%118.67%
Upgrade
Cost of Revenue
760.03743.99650.26390.83184.47128.7461.6231.9721.049.93
Upgrade
Gross Profit
1,8421,6631,382703.13368.84289.17171.6691.1956.3433.6
Upgrade
Selling, General & Admin
1,3671,3011,105886.88339.07265.16180.3116.8192.538.66
Upgrade
Research & Development
348.52333.63311.88164.9464.6454.3734.4621.8214.217.57
Upgrade
Other Operating Expenses
375.1213,682230.88157.7345.5745.9932.2915.235.412.52
Upgrade
Operating Expenses
2,09115,3161,6481,210449.28365.53247.05153.85112.1348.75
Upgrade
Operating Income
-248.55-13,653.21-265.63-506.42-80.44-76.35-75.39-62.66-55.79-15.15
Upgrade
Interest Expense / Income
22.2821.9481.1459.9529.3626.1117.492.592.21.5
Upgrade
Other Expense / Income
-51.23-11.8237.889.62-0.34-5.514.128.45--
Upgrade
Pretax Income
-219.61-13,663.34-384.66-575.99-109.46-96.97-107.01-73.71-57.98-16.65
Upgrade
Income Tax
0.76-3.8144.14-90.86-10.590.12-0.230.510.040.39
Upgrade
Net Income
-220.37-13,659.53-428.79-485.14-98.86-97.08-106.78-74.22-58.02-17.04
Upgrade
Shares Outstanding (Basic)
1651611579172665542202
Upgrade
Shares Outstanding (Diluted)
1651611579172665542202
Upgrade
Shares Change
1.93%2.88%73.40%25.98%9.11%18.79%30.94%112.53%914.72%60.59%
Upgrade
EPS (Basic)
-1.34-84.60-2.73-5.36-1.38-1.47-1.93-1.75-2.91-10.25
Upgrade
EPS (Diluted)
-1.34-84.60-2.73-5.36-1.38-1.47-1.93-1.75-2.91-10.25
Upgrade
Free Cash Flow
193.6716.53130.06-79.5518.97-13.27-37.07-53.98-53.46-13.09
Upgrade
Free Cash Flow Per Share
1.180.100.83-0.880.26-0.20-0.67-1.27-2.68-6.67
Upgrade
Gross Margin
70.80%69.09%68.01%64.27%66.66%69.20%73.58%74.04%72.81%77.19%
Upgrade
Operating Margin
-9.55%-567.27%-13.07%-46.29%-14.54%-18.27%-32.32%-50.88%-72.09%-34.81%
Upgrade
Profit Margin
-8.47%-567.53%-21.09%-44.35%-17.87%-23.23%-45.77%-60.26%-74.98%-39.14%
Upgrade
Free Cash Flow Margin
7.44%0.69%6.40%-7.27%3.43%-3.17%-15.89%-43.83%-69.08%-30.08%
Upgrade
EBITDA
154-13,370.76-83.89-437.96-35.15-35.25-70.42-62.85-50.92-12.83
Upgrade
EBITDA Margin
5.92%-555.53%-4.13%-40.03%-6.35%-8.44%-30.19%-51.03%-65.80%-29.48%
Upgrade
Depreciation & Amortization
351.32270.64219.6278.0944.9535.619.18.274.862.32
Upgrade
EBIT
-197.33-13,641.4-303.52-516.04-80.1-70.85-89.52-71.12-55.79-15.15
Upgrade
EBIT Margin
-7.58%-566.78%-14.93%-47.17%-14.48%-16.95%-38.37%-57.75%-72.09%-34.81%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).